$ELVN

$59.65▲ +1.1% YTD

5 SEC 13D/G filings tracked · Last updated Sep 3, 2026

Filing History

News

ELVN ▲ +1.1% - Enliven Therapeutics, Inc.

CP $59.65▲ +1.1%Sep 3, 2026 · ThinkSabio Blog

$ELVN ELVN - Enliven Therapeutics to Present at Upcoming Investor Conferences…

News

ELVN ▲ +0.1% - Enliven Therapeutics, Inc.

CP $57.89▲ +0.1%Aug 31, 2026 · ThinkSabio Blog

$ELVN ELVN ELVN - Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting…

SEC 13D/G

ELVN - Enliven Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$61.28▲ 293.83%Aug 6, 2026 · ThinkSabio Blog

$ELVN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ELVN Enliven Therapeutics, Inc. : $61.28 Sector: Healthcare | Y…

SEC 13D/G

$ELVN SEC Filing Update (24-JUN-2026) | ThinkSabio - Stocks Simplified

$47.60▲ 205.91%Jun 24, 2026 · ThinkSabio Blog

SEC Filing Update: #ELVN : $47.60 Sector: Healthcare | YTD: 🔼+ 205.91% The SEC disclosed Today (24-JUN-2026) that ORBIMED ADVISORS LLC has DECREASED #…

SEC 13D/G

$ELVN SEC Filing Update (17-JUN-2026) | ThinkSabio - Stocks Simplified

$45.00▲ 189.20%Jun 17, 2026 · ThinkSabio Blog

SEC Filing Update: #ELVN : $45.00 Sector: Healthcare | YTD: 🔼+ 189.20% The SEC disclosed Today (17-JUN-2026) that ORBIMED ADVISORS LLC has DECREASED #…